A. Segonzac

498 total citations
12 papers, 403 citations indexed

About

A. Segonzac is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, A. Segonzac has authored 12 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in A. Segonzac's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (3 papers). A. Segonzac is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (3 papers). A. Segonzac collaborates with scholars based in France and Denmark. A. Segonzac's co-authors include Salomón Z. Langer, H. Schoemaker, Frank Larsen, Jagdev Sidhu, Gilles Grollier, Hans E. Schoemaker, E. Zarifian, H. Lôo, Anne‐Marie Galzin and D. Sechter and has published in prestigious journals such as Biological Psychiatry, Journal of Neurochemistry and European Journal of Pharmacology.

In The Last Decade

A. Segonzac

12 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Segonzac France 9 220 139 117 113 40 12 403
J. Buus Lassen Denmark 13 272 1.2× 188 1.4× 142 1.2× 89 0.8× 40 1.0× 28 517
A. C. Tait United Kingdom 9 141 0.6× 111 0.8× 120 1.0× 119 1.1× 34 0.8× 10 423
D.R. Thomas United Kingdom 8 196 0.9× 109 0.8× 200 1.7× 202 1.8× 31 0.8× 11 542
D. T. Greenwood United Kingdom 12 146 0.7× 111 0.8× 103 0.9× 132 1.2× 30 0.8× 18 427
G Allers France 11 188 0.9× 81 0.6× 140 1.2× 144 1.3× 13 0.3× 24 449
A Todrick United Kingdom 13 238 1.1× 208 1.5× 273 2.3× 142 1.3× 63 1.6× 22 708
Roger M. Pinder United Kingdom 12 231 1.1× 194 1.4× 104 0.9× 61 0.5× 94 2.4× 37 528
Tice Macedo Portugal 13 201 0.9× 199 1.4× 58 0.5× 77 0.7× 17 0.4× 16 603
H. Mengel Denmark 13 219 1.0× 94 0.7× 167 1.4× 310 2.7× 19 0.5× 23 625
J. L. Crammer United Kingdom 12 63 0.3× 146 1.1× 91 0.8× 110 1.0× 49 1.2× 31 510

Countries citing papers authored by A. Segonzac

Since Specialization
Citations

This map shows the geographic impact of A. Segonzac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Segonzac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Segonzac more than expected).

Fields of papers citing papers by A. Segonzac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Segonzac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Segonzac. The network helps show where A. Segonzac may publish in the future.

Co-authorship network of co-authors of A. Segonzac

This figure shows the co-authorship network connecting the top 25 collaborators of A. Segonzac. A scholar is included among the top collaborators of A. Segonzac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Segonzac. A. Segonzac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sidhu, Jagdev, et al.. (1997). Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans. Chirality. 9(7). 686–692. 95 indexed citations
2.
Schoemaker, H., et al.. (1989). Differences in the temperature dependence of drug interaction with the noradrenaline and serotonin transporters. Neuropharmacology. 28(8). 823–828. 9 indexed citations
3.
Poirier, M F, Anne‐Marie Galzin, H. Lôo, et al.. (1987). Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Biological Psychiatry. 22(3). 287–302. 38 indexed citations
4.
Segonzac, A., Hans E. Schoemaker, Christopher R. Lee, & Salomón Z. Langer. (1987). [3H]-5-Methoxytryptoline is not actively accumulated by rabbit platelets. Naunyn-Schmiedeberg s Archives of Pharmacology. 336(1). 1–4. 2 indexed citations
5.
Segonzac, A., Hans E. Schoemaker, & Salomón Z. Langer. (1987). Temperature Dependence of Drug Interaction with the Platelet 5‐Hydroxytryptamine Transporter: A Clue to the Imipramine Selectivity Paradox. Journal of Neurochemistry. 48(2). 331–339. 38 indexed citations
6.
Sz, Langer, et al.. (1985). 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.. PubMed. 192. 441–55. 8 indexed citations
8.
Segonzac, A., et al.. (1985). 5‐Methoxytryptoline, a Competitive Endocoid Acting at [3H]Imipramine Recognition Sites in Human Platelets. Journal of Neurochemistry. 45(1). 249–256. 37 indexed citations
9.
Poirier, M F, H. Lôo, Chawki Benkelfat, et al.. (1984). [3H]imipramine binding and [3H]5HT uptake in human blood platelets: Changes after one week chlorimipramine treatment. European Journal of Pharmacology. 106(3). 629–633. 52 indexed citations
10.
Langer, Salomón Z., et al.. (1984). MOLECULAR MECHANISMS IN IMIPRAMINE AND DESIPRAMINE BINDING TO SYNAPTIC MEMBRANES. Clinical Neuropharmacology. 7. S160–S160. 3 indexed citations
11.
Langer, Salomón Z., et al.. (1984). Possible endocrine role of the pineal gland for 6-methoxytetrahydro-β-carboline, a putative endogenous neuromodulator of the [3H]imipramine recognition site. European Journal of Pharmacology. 102(2). 379–380. 48 indexed citations
12.
Segonzac, A., et al.. (1984). Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers. Naunyn-Schmiedeberg s Archives of Pharmacology. 328(1). 33–37. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026